Anti-Proliferative and Apoptotic Activities of Rumex crispus

Sepideh Mohammadhosseinpour1,2, Mukund Bhandari1,3, Dallas A Lee1,4

  • 1Department of Biotechnology, Stephen F. Austin State University, The UT System, Nacogdoches, TX 75965, USA.

Life (Basel, Switzerland)
|January 26, 2024
PubMed

Insights

Researchers explored natural compounds for colorectal cancer treatment. A water-soluble fraction from Rumex crispus (L19) demonstrated significant anti-proliferative and apoptotic effects on cancer cells, showing promise as a novel therapeutic lead.

Area of Science:

  • Natural Product Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Colorectal cancer is a leading cause of cancer death globally.
  • Natural products offer potential anticancer agents with targeted efficacy and fewer side effects.
  • Water-soluble compounds are desirable for chemotherapy development.

Purpose of the Study:

  • To screen water-soluble compounds from Rumex crispus for anti-proliferative and apoptotic activity against human colorectal adenocarcinoma (DLD-1) cells.
  • To identify and validate a potent anticancer fraction for further development.
  • To investigate the molecular mechanisms underlying the observed anticancer effects.

Main Methods:

  • Screening of water-soluble Rumex crispus fractions against DLD-1 cells.
  • Dose-dependent anti-proliferative assays.
  • Caspase activity measurement via RT-qPCR.
  • Gene expression analysis using RT2 Profiler assay and microarray.

Main Results:

  • The L19 fraction of Rumex crispus exhibited significant dose-dependent anti-proliferative activity against DLD-1 cells.
  • The L19 fraction induced apoptosis by activating caspases and inflammatory pathways.
  • Gene expression analysis revealed activation of non-apoptotic genes contributing to the anticancer effect.

Conclusions:

  • The L19 fraction from Rumex crispus possesses validated anticancer properties.
  • This fraction acts through induction of apoptotic and inflammatory pathways.
  • The L19 fraction is a promising lead compound for developing novel colorectal cancer therapeutics.